Thalia Therapeutics Plc (AIM:THAT)
London · Delayed Price · Currency is GBP · Price in GBX 0.6710
-0.0290 (-4.14%)
Jul 24, 2026, 12:45 PM GMT
Thalia Therapeutics Market Cap
Thalia Therapeutics has a market cap or net worth of 5.83 million as of July 24, 2026. Its market cap has increased by 86.67% in one year.
Market Cap
5.83M
Enterprise Value
4.75M
Revenue
7.26K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
ChartMarket Cap Chart
Since May 3, 2017, Thalia Therapeutics's market cap has increased from 4.57M to 5.83M, an increase of 27.43%. That is a compound annual growth rate of 2.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 5.83M | 33.33% |
| Dec 31, 2025 | 4.37M | 110.82% |
| Dec 31, 2024 | 2.07M | -9.28% |
| Dec 29, 2023 | 2.28M | -47.18% |
| Dec 30, 2022 | 4.32M | -46.33% |
| Dec 31, 2021 | 8.06M | -46.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 13.44M |
| Palatin Technologies | 12.78M |
| Genflow Biosciences | 11.27M |
| Cizzle Biotechnology Holdings | 8.71M |
| OptiBiotix Health | 5.78M |
| Oxford BioDynamics | 5.36M |
| CRISM Therapeutics | 5.15M |
| Theracryf | 4.51M |